Yukito Ichinose

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

Tony Mok, Yi‐Long Wu, Sumitra Thongprasert et al. · New England Journal of Medicine · 2009 · 8.2K citations · Full text

A Randomized Trial of Adjuvant Chemotherapy with Uracil–Tegafur for Adenocarcinoma of the Lung

Harubumi Kato, Yukito Ichinose, Morio Ohta et al. · New England Journal of Medicine · 2004 · 828 citations · Full text

Interstitial Lung Disease in Japanese Patients with Lung Cancer

Shoji Kudoh, Harubumi Kato, Yutaka Nishiwaki et al. · American Journal of Respiratory and Critical Care Medicine · 2008 · 481 citations

Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial

Roy S. Herbst, Yan Sun, Wilfried Eberhardt et al. · The Lancet Oncology · 2010 · 417 citations · Full text

Second-line Treatment, Oncology, Metronomic Therapy +10

Phase III Study, V-15-32, of Gefitinib Versus Docetaxel in Previously Treated Japanese Patients With Non–Small-Cell Lung Cancer

Riichiroh Maruyama, Yutaka Nishiwaki, Tomohide Tamura et al. · Journal of Clinical Oncology · 2008 · 364 citations · Full text